Description: The data set contains 264 variables and 164 responses were received. The respondents were individuals working at DR-TB treatment facilities in South Africa.

The denominator could not be determined as some staff were shift workers or on leave during the visits to the DR-TB facilities. The estimated coverage of all staff exceeded 80%. Abstract: The primary aim of the study was to understand the adverse event reporting practices in drug-resistant TB (DR-TB) treatment facilities in South Africa and to develop appropriate interventions if needed. The specific objectives of the study were to understand experiences of healthcare professionals in adverse event reporting, map out the current adverse event reporting practices and identify best practices (based on successful reporting of adverse events) and then analyse the quality of adverse event reporting according to minimum requirements of National Pharmacovigilance Centre (NPC). The final objectives were to understand the activities of NGOs working in pharmacovigilance and their linkages to regulatory authorities and develop an intervention plan where required based on findings.

Administrative records

Face-to-face interview

All qualifying staff (doctors, matrons/facility managers, professional nurses, pharmacists and quality assurance managers) based at the selected DR-TB facilities.

No sample was selected. All qualifying staff (doctors, matrons/facility managers, professional nurses, pharmacists and quality assurance managers) based at the selected DR-TB facilities were approached to participate. Only those who consented to be interviewed participated in the study.